Hookipa Enterprise Value over EBITDA from 2010 to 2024
| HOOK Stock | USD 0.76 0.05 6.17% |
Enterprise Value Over EBITDA | First Reported 2010-12-31 | Previous Quarter 0.41745091 | Current Value 0.44 | Quarterly Volatility 7.03559909 |
Check Hookipa Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Hookipa main balance sheet or income statement drivers, such as Tax Provision of 454.6 K, Net Interest Income of 4.8 M or Interest Income of 5.2 M, as well as many exotic indicators such as Price To Sales Ratio of 3.61, Dividend Yield of 0.0 or PTB Ratio of 0.66. Hookipa financial statements analysis is a perfect complement when working with Hookipa Pharma Valuation or Volatility modules.
Hookipa | Enterprise Value over EBITDA |
About Hookipa Pharma Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Hookipa Pharma income statement, its balance sheet, and the statement of cash flows. Hookipa Pharma investors use historical funamental indicators, such as Hookipa Pharma's Enterprise Value over EBITDA, to determine how well the company is positioned to perform in the future. Although Hookipa Pharma investors may use each financial statement separately, they are all related. The changes in Hookipa Pharma's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Hookipa Pharma's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Hookipa Pharma Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Hookipa Pharma. Please read more on our technical analysis and fundamental analysis pages.
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company was incorporated in 2011 and is headquartered in New York, New York. Hookipa Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 131 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Hookipa Pharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Hookipa Pharma's short interest history, or implied volatility extrapolated from Hookipa Pharma options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out the analysis of Hookipa Pharma Correlation against competitors. For more information on how to buy Hookipa Stock please use our How to buy in Hookipa Stock guide.You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for Hookipa Stock analysis
When running Hookipa Pharma's price analysis, check to measure Hookipa Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hookipa Pharma is operating at the current time. Most of Hookipa Pharma's value examination focuses on studying past and present price action to predict the probability of Hookipa Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hookipa Pharma's price. Additionally, you may evaluate how the addition of Hookipa Pharma to your portfolios can decrease your overall portfolio volatility.
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |
Is Hookipa Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Hookipa Pharma. If investors know Hookipa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Hookipa Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.86) | Revenue Per Share 0.213 | Quarterly Revenue Growth (0.05) | Return On Assets (0.32) | Return On Equity (0.85) |
The market value of Hookipa Pharma is measured differently than its book value, which is the value of Hookipa that is recorded on the company's balance sheet. Investors also form their own opinion of Hookipa Pharma's value that differs from its market value or its book value, called intrinsic value, which is Hookipa Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Hookipa Pharma's market value can be influenced by many factors that don't directly affect Hookipa Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Hookipa Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Hookipa Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Hookipa Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.